Mason Carrico
Stock Analyst at Stephens & Co.
(2.02)
# 2,970
Out of 4,944 analysts
71
Total ratings
35.48%
Success rate
-3.67%
Average return
Main Sectors:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Reiterates: Overweight | $67 | $36.54 | +83.36% | 3 | Jun 16, 2025 | |
| ILMN Illumina | Reiterates: Overweight | $105 | $97.38 | +7.83% | 8 | May 20, 2025 | |
| PACB Pacific Biosciences of California | Reiterates: Overweight | $1.8 | $1.21 | +48.76% | 5 | May 15, 2025 | |
| TXG 10x Genomics | Reiterates: Overweight | $14 | $12.81 | +9.29% | 6 | May 15, 2025 | |
| HOLX Hologic | Maintains: Overweight | $77 → $70 | $67.95 | +3.02% | 4 | May 13, 2025 | |
| CDNA CareDx | Reiterates: Overweight | $40 | $12.46 | +221.03% | 10 | May 5, 2025 | |
| GKOS Glaukos | Maintains: Overweight | $140 → $115 | $89.34 | +28.72% | 1 | May 2, 2025 | |
| VCYT Veracyte | Reiterates: Overweight | $45 | $28.77 | +56.41% | 7 | Mar 26, 2025 | |
| GH Guardant Health | Reiterates: Overweight | $55 | $55.10 | -0.18% | 5 | Mar 26, 2025 | |
| CTKB Cytek Biosciences | Reiterates: Overweight | $6 | $4.03 | +48.88% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $17 | $27.39 | -37.93% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 | $33.62 | +54.67% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $20 | $6.03 | +231.67% | 4 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $41 | $19.33 | +112.11% | 7 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $125 | $159.81 | -21.78% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $19 | $6.08 | +212.50% | 1 | Jul 30, 2024 |
Vericel
Jun 16, 2025
Reiterates: Overweight
Price Target: $67
Current: $36.54
Upside: +83.36%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $97.38
Upside: +7.83%
Pacific Biosciences of California
May 15, 2025
Reiterates: Overweight
Price Target: $1.8
Current: $1.21
Upside: +48.76%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $12.81
Upside: +9.29%
Hologic
May 13, 2025
Maintains: Overweight
Price Target: $77 → $70
Current: $67.95
Upside: +3.02%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $12.46
Upside: +221.03%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140 → $115
Current: $89.34
Upside: +28.72%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $28.77
Upside: +56.41%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $55.10
Upside: -0.18%
Cytek Biosciences
Mar 19, 2025
Reiterates: Overweight
Price Target: $6
Current: $4.03
Upside: +48.88%
Mar 18, 2025
Reiterates: Equal-Weight
Price Target: $17
Current: $27.39
Upside: -37.93%
Mar 6, 2025
Reiterates: Overweight
Price Target: $52
Current: $33.62
Upside: +54.67%
Jan 16, 2025
Reiterates: Equal-Weight
Price Target: $20
Current: $6.03
Upside: +231.67%
Jan 2, 2025
Reiterates: Overweight
Price Target: $41
Current: $19.33
Upside: +112.11%
Aug 9, 2024
Reiterates: Overweight
Price Target: $125
Current: $159.81
Upside: -21.78%
Jul 30, 2024
Reiterates: Overweight
Price Target: $19
Current: $6.08
Upside: +212.50%